Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPS: Cathflo Activase in Pediatric Dysfunctional CVADs
NCT00307580Phase 4Completed
- Sponsor
- Genentech
- Start
- Apr 2002
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of tissue-plasminogen activator in central venous catheter occlusion, sponsored by Genentech. Started Apr 2002; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
central venous catheter occlusion
Beyond the preview
Go deeper on NCT00307580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307580.